- Company Directors - C
- Crane Alan L
Insider Trading History of Crane Alan L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Crane Alan L since 2006.
The trader's CIK number is 1294361.
At the time of the last reporting, Crane Alan L was the Officer of Pandion Therapeutics, Inc.. (stock ticker symbol PAND).
Also see all insider trading activities at Pandion Therapeutics, Inc..
Note that in the past
Crane Alan L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Crane Alan L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | MNTA | 0 | $0 | 0 | $0 | 35,200 | $103,840 |
| 2007 | MNTA | 0 | $0 | 50,000 | $872,300 | 0 | $0 |
| 2006 | MNTA | 0 | $0 | 530,464 | $8,438,341 | 0 | $0 |
Yearly summary of insider trading at Dare Bioscience, Inc. (CERU) by Crane Alan L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CERU | 1,470,582 | $10,294,074 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at T2 Biosystems, Inc. (TTOO) by Crane Alan L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | TTOO | 30,000 | $330,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pandion Therapeutics, Inc. (PAND) by Crane Alan L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PAND | 50,111 | $901,998 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Crane Alan L:
1. Momenta Pharmaceuticals Inc (MNTA)
2. Dare Bioscience, Inc. (CERU)
3. T2 Biosystems, Inc. (TTOO)
4. Pandion Therapeutics, Inc. (PAND)
Table 1. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Crane Alan L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-04-14 | MNTA | Option Ex | 35,200 | 2.95 | 103,840 |
| 2007-01-10 | MNTA | Sale | 50,000 | 17.45 | 872,300 |
| 2006-12-18 | MNTA | Sale | 62,500 | 16.42 | 1,026,500 |
| 2006-12-08 | MNTA | Sale | 50,000 | 17.62 | 880,850 |
| 2006-11-16 | MNTA | Sale | 62,500 | 16.37 | 1,023,250 |
| 2006-11-08 | MNTA | Sale | 50,000 | 15.19 | 759,450 |
| 2006-10-12 | MNTA | Sale | 15,300 | 15.00 | 229,500 |
| 2006-10-13 | MNTA | Sale | 14,932 | 15.00 | 223,980 |
| 2006-10-10 | MNTA | Sale | 9,856 | 15.00 | 147,840 |
| 2006-10-11 | MNTA | Sale | 10,200 | 15.00 | 153,000 |
| 2006-09-11 | MNTA | Sale | 50,000 | 15.05 | 752,500 |
| 2006-09-12 | MNTA | Sale | 38,174 | 15.00 | 572,610 |
| 2006-09-07 | MNTA | Sale | 12,402 | 15.35 | 190,370 |
| 2006-09-05 | MNTA | Sale | 21,600 | 15.90 | 343,375 |
| 2006-08-30 | MNTA | Sale | 50,000 | 16.41 | 820,700 |
| 2006-08-31 | MNTA | Sale | 33,000 | 16.47 | 543,378 |
| 2006-08-08 | MNTA | Sale | 20,300 | 15.73 | 319,420 |
| 2006-08-09 | MNTA | Sale | 29,700 | 15.21 | 451,618 |
Table 2. Insider trading of Dare Bioscience, Inc. (CERU) by Crane Alan L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-04-15 | CERU | Buy | 1,470,582 | 7.00 | 10,294,074 |
Table 3. Insider trading of T2 Biosystems, Inc. (TTOO) by Crane Alan L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-08-12 | TTOO | Buy | 30,000 | 11.00 | 330,000 |
Table 4. Insider trading of Pandion Therapeutics, Inc. (PAND) by Crane Alan L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-21 | PAND | Buy | 50,111 | 18.00 | 901,998 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Crane Alan L
(Officer of Pandion Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.